RxSight 公司
US ˙ NasdaqGM ˙ US78349D1072

SecurityRXST / RxSight, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership609,904 shares
Latest Disclosed Value $ 3,757,010
Morgan Stanley reports 20.28% decrease in ownership of RXST / RxSight, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 609,904 shares of RxSight, Inc. (US:RXST) valued at $3,757,009 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 765,025 shares of RxSight, Inc.. This represents a change in shares of -20.28% during the quarter. The current value of the position is $3,110,510 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F RXSIGHT COM 78349D107 609,904 -155,121 -20.28 3,757 -52.87 0.0002
2026-05-27 2025-12-31 13F/A-1 RXSIGHT COM 78349D107 765,025 -79,628 -9.43 7,972 4.98 0.0005
2026-02-13 2025-12-31 13F RXSIGHT COM 78349D107 765,025 -79,628 7,972 0.0005
2026-05-27 2025-09-30 13F/A-1 RXSIGHT COM 78349D107 844,653 -157,070 -15.68 7,593 -41.69 0.0005
2025-11-14 2025-09-30 13F RXSIGHT COM 78349D107 844,653 -157,070 7,593 0.0005
2025-08-15 2025-06-30 13F RXSIGHT COM 78349D107 1,001,723 595,337 146.50 13,022 26.91 0.0008
2025-05-15 2025-03-31 13F RXSIGHT COM 78349D107 406,386 14,187 3.62 10,261 -23.90 0.0007
2025-05-15 2024-12-31 13F/A-1 RXSIGHT COM 78349D107 392,199 -94,701 -19.45 13,484 -43.98 0.0009
2025-02-14 2024-12-31 13F RXSIGHT COM 78349D107 392,199 -94,701 13,484 0.0009
2025-05-14 2024-09-30 13F/A-2 RXSIGHT COM 78349D107 486,900 -630,358 -56.42 24,068 -64.20 0.0017
2025-02-14 2024-09-30 13F/A-1 RXSIGHT COM 78349D107 486,900 -630,358 24,068 0.0017
2024-11-14 2024-09-30 13F RXSIGHT COM 78349D107 486,900 -630,358 24,068 0.0017
2025-05-14 2024-06-30 13F/A-2 RXSIGHT COM 78349D107 1,117,258 -8,393 -0.75 67,225 15.78 0.0052
2024-10-17 2024-06-30 13F/A-1 RXSIGHT COM 78349D107 1,117,258 -8,393 67,225 0.0052
2024-08-14 2024-06-30 13F RXSIGHT COM 78349D107 1,117,258 -8,393 67,225 0.0052
2024-10-17 2024-03-31 13F/A-2 RXSIGHT COM 78349D107 1,125,651 52,589 4.90 58,061 34.20 0.0047
2024-08-16 2024-03-31 13F/A-1 RXSIGHT COM 78349D107 1,125,651 52,589 58,061 0.0005
2024-05-15 2024-03-31 13F RXSIGHT COM 78349D107 1,125,651 52,589 58,061 0.0047
2024-08-16 2023-12-31 13F/A-1 RXSIGHT COM 78349D107 1,073,062 -138,342 -11.42 43,266 28.06 0.0038
2024-02-13 2023-12-31 13F RXSIGHT COM 78349D107 1,073,062 -138,342 43,266 0.0038
2023-11-15 2023-09-30 13F RXSIGHT COM 78349D107 1,211,404 -295,671 -19.62 33,786 -22.16 0.0034
2023-08-14 2023-06-30 13F RXSIGHT COM 78349D107 1,507,075 1,451,598 2,616.58 43,404 4,592.22 0.0043
2023-05-15 2023-03-31 13F RXSIGHT COM 78349D107 55,477 32,008 136.38 925 211.45 0.0001
2023-02-14 2022-12-31 13F RXSIGHT COM 78349D107 23,469 -3,735 -13.73 297 -8.90 0.0000
2022-11-14 2022-09-30 13F RXSIGHT COM 78349D107 27,204 17,708 186.48 326 143.28 0.0000
2022-10-27 2022-06-30 13F/A-1 RXSIGHT COM 78349D107 9,496 5,964 168.86 134 204.55 0.0000
2022-08-15 2022-06-30 13F RXSIGHT COM 78349D107 9,496 5,964 134 0.0000
2022-10-27 2022-03-31 13F/A-1 RXSIGHT COM 78349D107 3,532 1,515 75.11 44 91.30 0.0000
2022-05-13 2022-03-31 13F RXSIGHT COM 78349D107 3,532 1,515 44 0.0000
2022-02-14 2021-12-31 13F RXSIGHT COM 78349D107 2,017 478 31.06 23 21.05 0.0000
2021-11-15 2021-09-30 13F RXSIGHT COM 78349D107 1,539 1,539 19 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.